{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T03:32:12Z","timestamp":1785123132536,"version":"3.55.0"},"reference-count":41,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Semaphorin3A (Sema3A) is a regulatory protein found to be expressed on regulatory T and B cells and also secreted into peripheral blood. It has been identified as a potent immune regulator; however, not all its regulatory mechanisms have been evaluated. In this respect, we aim to investigate how Sema3A affects key metabolic pathways in T cells during homeostasis and rheumatoid arthritis (RA), and on the AKT\/mTORC1 signaling axis. In this study, peripheral blood samples were collected from 119 healthy donors and 32 rheumatoid arthritis patients. T cells were subjected to Seahorse analysis to evaluate OXPHOS and glycolysis, live cell TMRE staining to evaluate mitochondrial activity, mass spectrometry for metabolite profiling, ATP determination to study ATP production, and Western blot analysis to investigate the signaling pathway activity. This study presents evidence showing that Sema3A inhibits the AKT\/mTORC1 pathway, leading to a decreased glucose uptake and glycolysis disruption. Furthermore, we show that Sema3A reduces mitochondrial capacity and OXPHOS in activated T cells of healthy and RA donors, leading to a decreased ATP production. In contrast, Sema3A upregulates fatty acid oxidation (FA), probably as a backup pathway to ensure cell survival. Results with p values of &lt;0.05 were considered significant. Our data may point to Sema3A\u2019s ability to convert activated T cells\u2019 metabolic profile back to its non-activated state. This may suggest that Sema3A might be a beneficial treatment for immune-mediated diseases by metabolically reprogramming activated T cells.<\/jats:p>","DOI":"10.3390\/ijms262211160","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T08:50:07Z","timestamp":1763542207000},"page":"11160","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Semaphorin3A Rewires CD4+ T-Cell Metabolism via AKT\/mTORC1 Inhibition in Health and Rheumatoid Arthritis"],"prefix":"10.3390","volume":"26","author":[{"given":"Raeda","family":"Mubariki","sequence":"first","affiliation":[{"name":"Proteomic Unit, Bnai Zion Medical Center, Haifa 3478403, Israel"},{"name":"Rappaport Faculty of Medicine, Technion, Haifa 3478403, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasren","family":"Eiza","sequence":"additional","affiliation":[{"name":"Proteomic Unit, Bnai Zion Medical Center, Haifa 3478403, Israel"},{"name":"Rappaport Faculty of Medicine, Technion, Haifa 3478403, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi D.","family":"Sabag","sequence":"additional","affiliation":[{"name":"Proteomic Unit, Bnai Zion Medical Center, Haifa 3478403, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiri","family":"Keret","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Bnai Zion Medical Center, Haifa 3478403, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doron","family":"Rimar","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Bnai Zion Medical Center, Haifa 3478403, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gleb","family":"Slobodin","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Bnai Zion Medical Center, Haifa 3478403, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0523-2292","authenticated-orcid":false,"given":"Devy","family":"Zisman","sequence":"additional","affiliation":[{"name":"Rheumatology Out-Patient Clinic, \u201cLin\u201d-Clalit Health Services (OMG), Haifa 3478403, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Toubi","sequence":"additional","affiliation":[{"name":"Rappaport Faculty of Medicine, Technion, Haifa 3478403, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahava","family":"Vadasz","sequence":"additional","affiliation":[{"name":"Proteomic Unit, Bnai Zion Medical Center, Haifa 3478403, Israel"},{"name":"Rappaport Faculty of Medicine, Technion, Haifa 3478403, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41590-018-0045-y","article-title":"Metabolic exhaustion in infection, cancer and autoimmunity review-article","volume":"19","author":"McKinney","year":"2018","journal-title":"Nat. Immunol."},{"key":"ref_2","first-page":"911","article-title":"S Usceptibility To a Utoimmune and a Llergic D Iseases","volume":"347","author":"Of","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/icb.2016.77","article-title":"Immunometabolism and autoimmunity","volume":"94","author":"Freitag","year":"2016","journal-title":"Immunol. Cell Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2013.04.005","article-title":"Metabolic pathways in immune cell activation and quiescence","volume":"38","author":"Pearce","year":"2013","journal-title":"Immunity"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000521305","article-title":"Immunometabolism: Where Immunology and Metabolism Meet","volume":"14","author":"Chavakis","year":"2022","journal-title":"J. Innate Immun."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41423-022-00840-x","article-title":"Immunometabolism at the intersection of metabolic signaling, cell fate, and systems immunology","volume":"19","author":"Chi","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/25785826.2018.1531186","article-title":"Immunometabolism in rheumatoid arthritis","volume":"41","author":"Okano","year":"2018","journal-title":"Immunol. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1084\/jem.20151159","article-title":"T cell metabolism drives immunity","volume":"212","author":"Buck","year":"2015","journal-title":"J. Exp. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e200012","DOI":"10.20900\/immunometab20200012","article-title":"Metabolic Targets for Treatment of Autoimmune Diseases","volume":"2","author":"Piranavan","year":"2020","journal-title":"Immunometabolism"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1172\/JCI76012","article-title":"Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation","volume":"125","author":"Gerriets","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e210032","DOI":"10.20900\/immunometab20210032","article-title":"Immunometabolism: An Emerging Target for Immunotherapies to Treat Rheumatoid Arthritis","volume":"3","author":"Mangal","year":"2021","journal-title":"Immunometabolism"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nrrheum.2017.49","article-title":"Immunometabolism in early and late stages of rheumatoid arthritis","volume":"13","author":"Weyand","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/imr.12838","article-title":"Immunometabolism in the development of rheumatoid arthritis","volume":"294","author":"Weyand","year":"2020","journal-title":"Immunol. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1177\/0961203312456753","article-title":"Semaphorin 3A-a marker for disease activity and a potential putative disease-modifying treatment in systemic lupus erythematosus","volume":"21","author":"Vadasz","year":"2012","journal-title":"Lupus"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2018.00634","article-title":"Semaphorin3A: A potential therapeutic tool for lupus nephritis","volume":"9","author":"Bejar","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s00296-015-3269-2","article-title":"Semaphorin 3A: An immunoregulator in systemic sclerosis","volume":"35","author":"Rimar","year":"2015","journal-title":"Rheumatol. Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.clim.2017.05.011","article-title":"Semaphorin 3A: Is a key player in the pathogenesis of asthma","volume":"184","author":"Cozacov","year":"2017","journal-title":"Clin. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.4049\/jimmunol.0903527","article-title":"The Neuroimmune Semaphorin-3A Reduces Inflammation and Progression of Experimental Autoimmune Arthritis","volume":"185","author":"Catalano","year":"2010","journal-title":"J. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Eiza, N., Kessler, O., Sabag, A., Neufeld, G., Jones, E.Y., and Vadasz, Z. (2023). Truncated-semaphorin3A is a potential regulatory molecule to restore immune homeostasis in immune-mediated diseases. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.1085892"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/alr.22274","article-title":"Semaphorin 3A inhibits allergic inflammation by regulating immune responses in a mouse model of allergic rhinitis","volume":"9","author":"Xiang","year":"2019","journal-title":"Int. Forum Allergy Rhinol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/all.14026","article-title":"Semaphorin3A is a promising therapeutic tool for bronchial asthma","volume":"75","author":"Toubi","year":"2020","journal-title":"Allergy Eur. J. Allergy Clin. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s10787-018-0484-y","article-title":"Emerging role of semaphorin-3A in autoimmune diseases","volume":"26","author":"Liu","year":"2018","journal-title":"Inflammopharmacology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1002\/eji.200535601","article-title":"Immunosuppressive role of semaphorin-3A on T cell proliferation is mediated by inhibition of actin cytoskeleton reorganization","volume":"36","author":"Lepelletier","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.canlet.2016.09.003","article-title":"T-cell immunometabolism against cancer","volume":"382","author":"Jiang","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00011-018-1174-3","article-title":"Immunometabolism of T cells and NK cells: Metabolic control of effector and regulatory function","volume":"67","author":"Poznanski","year":"2018","journal-title":"Inflamm. Res."},{"key":"ref_26","first-page":"113","article-title":"Semaphorin-3A as An Immune Modulator Is Suppressed by MicroRNA-145-5p","volume":"20","author":"Rezaeepoor","year":"2018","journal-title":"Cell J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e14321","DOI":"10.1111\/acel.14321","article-title":"Chronic \u03b23-AR stimulation activates distinct thermogenic mechanisms in brown and white adipose tissue and improves systemic metabolism in aged mice","volume":"23","author":"Natarajan","year":"2024","journal-title":"Aging Cell"},{"key":"ref_28","first-page":"145","article-title":"Sources and implications of NADH\/NAD+ redox imbalance in diabetes and its complications","volume":"9","author":"Wu","year":"2016","journal-title":"Diabetes, Metab. Syndr. Obes."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1016\/j.bbagen.2012.10.020","article-title":"The fairytale of the GSSG\/GSH redox potential","volume":"1830","year":"2013","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/s42255-020-0250-5","article-title":"Dihydroxyacetone phosphate signals glucose availability to mTORC1","volume":"2","author":"Orozco","year":"2020","journal-title":"Nat. Metab."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1006\/excr.1999.4683","article-title":"Ribosomal S6 kinase signaling and the control of translation","volume":"253","author":"Dufner","year":"1999","journal-title":"Exp. Cell Res."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"St\u00f6ckl, S., Reichart, J., Zborilova, M., Johnstone, B., and Gr\u00e4ssel, S. (2022). Semaphorin 3A-Neuropilin-1 Signaling Modulates MMP13 Expression in Human Osteoarthritic Chondrocytes. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232214180"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"5703651","DOI":"10.1155\/2018\/5703651","article-title":"Semaphorin 3A Inhibits Inflammation in Chondrocytes under Excessive Mechanical Stress","volume":"2018","author":"Sumi","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Sang, Y., Tsuji, K., Inoue-torii, A., Fukushima, K., and Kitamura, S. (2020). Semaphorin3A-Inhibitor Ameliorates Doxorubicin-Induced Podocyte Injury. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21114099"},{"key":"ref_35","first-page":"139","article-title":"Bioenergetics in T. cells using a SEF, G Measuring bioenergetics in T cells using a Seahorse","volume":"176","author":"Analyzer","year":"2017","journal-title":"Physiol. Behav."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"13106","DOI":"10.1096\/fj.202000767R","article-title":"Mitochondrial spare respiratory capacity: Mechanisms, regulation, and significance in non-transformed and cancer cells","volume":"34","author":"Marchetti","year":"2020","journal-title":"FASEB J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","article-title":"The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation","volume":"7","author":"DeBerardinis","year":"2008","journal-title":"Cell Metab."},{"key":"ref_38","first-page":"1","article-title":"Evaluation of the mitochondrial respiratory Chain and oxidative phosphorylation system using polarography and spectrophotometric enzyme assays","volume":"19","author":"Barrientos","year":"2009","journal-title":"Curr. Protoc. Hum. Genet."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1101\/pdb.prot087361","article-title":"Measuring mitochondrial transmembrane potential by TMRE staining","volume":"2016","author":"Crowley","year":"2016","journal-title":"Cold Spring Harb. Protoc."},{"key":"ref_40","unstructured":"(1997). Chapter 2 Biochemical targets for anthelmintic activity. Pharmacochem. Libr., 25, 46\u201370."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"9666","DOI":"10.1073\/pnas.171301998","article-title":"p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD","volume":"98","author":"Harada","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/22\/11160\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T08:53:11Z","timestamp":1763542391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/22\/11160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":41,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["ijms262211160"],"URL":"https:\/\/doi.org\/10.3390\/ijms262211160","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]}}}